Literature DB >> 12695060

Influence of the surface characteristics of PVM/MA nanoparticles on their bioadhesive properties.

P Arbós1, M A Campanero, M A Arangoa, M J Renedo, J M Irache.   

Abstract

The aim of this work was to investigate the influence of the cross-linkage of poly(methylvinylether-co-maleic anhydride) (PVM/MA) nanoparticles with increasing amounts of 1,3-diaminopropane (DP) and, eventually, bovine serum albumin (BSA) on their gastrointestinal transit and bioadhesive properties. The fluorescently-labelled formulations were orally administered to rats and, at different times, the amount of nanoparticles in both the lumen content and adhered to the gut mucosa were quantified. The gut transit was evaluated by calculating the gastric (k(ge)) and intestinal (k(ie)) emptying rates. The adhered fraction of nanoparticles in the whole gut was plotted versus time and, from these curves, the intensity, capacity and extent of the adhesive interactions were estimated. The bioadhesive potential of PVM/MA was much higher when formulated as nanoparticles (NP) than in the solubilised form in water. However, k(ge) and k(ie) increased by increasing the extent of cross-linkage of nanoparticles with DP, while the capacity to develop adhesive interactions and the intensity of the adhesive phenomenon were significantly higher for non-hardened than for DP-cross-linked carriers. In contrast, the BSA-coating of cross-linked nanoparticles significantly decreased k(ge) and k(gi), whereas the intensity of the bioadhesive phenomenon was significantly higher than for NP. In summary, the adhesivity of the nanoparticles appears to modulate their gastrointestinal transit profile.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12695060     DOI: 10.1016/s0168-3659(03)00066-x

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  15 in total

Review 1.  Methods for the preparation and manufacture of polymeric nanoparticles.

Authors:  Christine Vauthier; Kawthar Bouchemal
Journal:  Pharm Res       Date:  2008-12-24       Impact factor: 4.200

2.  High loading of gentamicin in bioadhesive PVM/MA nanostructured microparticles using compressed carbon-dioxide.

Authors:  Elisa Elizondo; Santiago Sala; Edurne Imbuluzqueta; David González; María J Blanco-Prieto; Carlos Gamazo; Nora Ventosa; Jaume Veciana
Journal:  Pharm Res       Date:  2010-12-02       Impact factor: 4.200

3.  Molecular imaging techniques to study the biodistribution of orally administered (99m)Tc-labelled naive and ligand-tagged nanoparticles.

Authors:  Paloma Areses; Ma Teresa Agüeros; Gemma Quincoces; María Collantes; José Ángel Richter; Luisa Ma López-Sánchez; María Sánchez-Martínez; Juan M Irache; Iván Peñuelas
Journal:  Mol Imaging Biol       Date:  2011-12       Impact factor: 3.488

4.  Design of estradiol loaded PLGA nanoparticulate formulations: a potential oral delivery system for hormone therapy.

Authors:  S Hariharan; V Bhardwaj; I Bala; J Sitterberg; U Bakowsky; M N V Ravi Kumar
Journal:  Pharm Res       Date:  2006-11-08       Impact factor: 4.200

Review 5.  The Use of Physiologically Based Pharmacokinetic Analyses-in Biopharmaceutics Applications -Regulatory and Industry Perspectives.

Authors:  Om Anand; Xavier J H Pepin; Vidula Kolhatkar; Paul Seo
Journal:  Pharm Res       Date:  2022-05-18       Impact factor: 4.580

6.  Evaluation of bioadhesive capacity and immunoadjuvant properties of vitamin B(12)-Gantrez nanoparticles.

Authors:  Hesham H Salman; Carlos Gamazo; P Chris de Smidt; Gregory Russell-Jones; Juan M Irache
Journal:  Pharm Res       Date:  2008-08-05       Impact factor: 4.200

Review 7.  Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues.

Authors:  Samuel K Lai; Ying-Ying Wang; Justin Hanes
Journal:  Adv Drug Deliv Rev       Date:  2008-12-13       Impact factor: 15.470

8.  Immunogenicity of peanut proteins containing poly(anhydride) nanoparticles.

Authors:  Juliana De S Rebouças; Juan M Irache; Ana I Camacho; Gabriel Gastaminza; María L Sanz; Marta Ferrer; Carlos Gamazo
Journal:  Clin Vaccine Immunol       Date:  2014-06-04

Review 9.  Nanoparticulate adjuvants and delivery systems for allergen immunotherapy.

Authors:  Juliana De Souza Rebouças; Irene Esparza; Marta Ferrer; María Luisa Sanz; Juan Manuel Irache; Carlos Gamazo
Journal:  J Biomed Biotechnol       Date:  2012-02-26

10.  Luteinizing hormone-releasing hormone targeted poly(methyl vinyl ether maleic acid) nanoparticles for doxorubicin delivery to MCF-7 breast cancer cells.

Authors:  Jaleh Varshosaz; Ali Jahanian-Najafabadi; Jila Ghazzavi
Journal:  IET Nanobiotechnol       Date:  2016-08       Impact factor: 1.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.